These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 21706033)

  • 1. Discovery of selective bioactive small molecules by targeting an RNA dynamic ensemble.
    Stelzer AC; Frank AT; Kratz JD; Swanson MD; Gonzalez-Hernandez MJ; Lee J; Andricioaei I; Markovitz DM; Al-Hashimi HM
    Nat Chem Biol; 2011 Jun; 7(8):553-9. PubMed ID: 21706033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Face-time with TAR: Portraits of an HIV-1 RNA with diverse modes of effector recognition relevant for drug discovery.
    Chavali SS; Bonn-Breach R; Wedekind JE
    J Biol Chem; 2019 Jun; 294(24):9326-9341. PubMed ID: 31080171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of TAR RNA complexed with a Tat-TAR interaction nanomolar inhibitor that was identified by computational screening.
    Du Z; Lind KE; James TL
    Chem Biol; 2002 Jun; 9(6):707-12. PubMed ID: 12079782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design-Based Peptidomimetic Ligand Discovery to Target HIV TAR RNA Using Comparative Analysis of Different Docking Methods.
    Fu J; Xia A; Dai Y; Qi X
    Curr HIV Res; 2016; 14(6):476-483. PubMed ID: 27450546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA.
    Lind KE; Du Z; Fujinaga K; Peterlin BM; James TL
    Chem Biol; 2002 Feb; 9(2):185-93. PubMed ID: 11880033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecules targeted to a non-catalytic "RVxF" binding site of protein phosphatase-1 inhibit HIV-1.
    Ammosova T; Platonov M; Yedavalli VR; Obukhov Y; Gordeuk VR; Jeang KT; Kovalskyy D; Nekhai S
    PLoS One; 2012; 7(6):e39481. PubMed ID: 22768081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-performance virtual screening by targeting a high-resolution RNA dynamic ensemble.
    Ganser LR; Lee J; Rangadurai A; Merriman DK; Kelly ML; Kansal AD; Sathyamoorthy B; Al-Hashimi HM
    Nat Struct Mol Biol; 2018 May; 25(5):425-434. PubMed ID: 29728655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication.
    Hamy F; Felder ER; Heizmann G; Lazdins J; Aboul-ela F; Varani G; Karn J; Klimkait T
    Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3548-53. PubMed ID: 9108013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tat-transactivating response element (TAR) RNA.
    Lalonde MS; Lobritz MA; Ratcliff A; Chamanian M; Athanassiou Z; Tyagi M; Wong J; Robinson JA; Karn J; Varani G; Arts EJ
    PLoS Pathog; 2011 May; 7(5):e1002038. PubMed ID: 21625572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of biologically active, HIV TAR RNA-binding small molecules using small molecule microarrays.
    Sztuba-Solinska J; Shenoy SR; Gareiss P; Krumpe LR; Le Grice SF; O'Keefe BR; Schneekloth JS
    J Am Chem Soc; 2014 Jun; 136(23):8402-10. PubMed ID: 24820959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a small molecule Tat-trans-activation-responsive RNA antagonist that potently inhibits human immunodeficiency virus-1 replication.
    Hwang S; Tamilarasu N; Kibler K; Cao H; Ali A; Ping YH; Jeang KT; Rana TM
    J Biol Chem; 2003 Oct; 278(40):39092-103. PubMed ID: 12857725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Small Molecules with a Noncanonical Binding Mode to HIV-1 Trans Activation Response (TAR) RNA.
    Abulwerdi FA; Shortridge MD; Sztuba-Solinska J; Wilson R; Le Grice SF; Varani G; Schneekloth JS
    J Med Chem; 2016 Dec; 59(24):11148-11160. PubMed ID: 28002966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replication of human immunodeficiency viruses engineered with heterologous Tat-transactivation response element interactions.
    Xie B; Wainberg MA; Frankel AD
    J Virol; 2003 Feb; 77(3):1984-91. PubMed ID: 12525632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of HIV-1 replication by anti-trans-activation responsive polyamide nucleotide analog.
    Kaushik N; Basu A; Pandey VN
    Antiviral Res; 2002 Oct; 56(1):13-27. PubMed ID: 12323396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous recognition of HIV-1 TAR RNA bulge and loop sequences by cyclic peptide mimics of Tat protein.
    Davidson A; Leeper TC; Athanassiou Z; Patora-Komisarska K; Karn J; Robinson JA; Varani G
    Proc Natl Acad Sci U S A; 2009 Jul; 106(29):11931-6. PubMed ID: 19584251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of HIV derived lentiviral production by TAR RNA binding domain of TAT protein.
    Mi MY; Zhang J; He Y
    Retrovirology; 2005 Nov; 2():71. PubMed ID: 16293193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of ligands for RNA targets via structure-based virtual screening: HIV-1 TAR.
    Filikov AV; Mohan V; Vickers TA; Griffey RH; Cook PD; Abagyan RA; James TL
    J Comput Aided Mol Des; 2000 Aug; 14(6):593-610. PubMed ID: 10921774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivalent binding oligomers inhibit HIV Tat-TAR interaction critical for viral replication.
    Wang D; Iera J; Baker H; Hogan P; Ptak R; Yang L; Hartman T; Buckheit RW; Desjardins A; Yang A; Legault P; Yedavalli V; Jeang KT; Appella DH
    Bioorg Med Chem Lett; 2009 Dec; 19(24):6893-7. PubMed ID: 19896372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration that Small Molecules can Bind and Stabilize Low-abundance Short-lived RNA Excited Conformational States.
    Ganser LR; Kelly ML; Patwardhan NN; Hargrove AE; Al-Hashimi HM
    J Mol Biol; 2020 Feb; 432(4):1297-1304. PubMed ID: 31863746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of HIV-1 Tat-mediated transactivation.
    Richter SN; Palù G
    Curr Med Chem; 2006; 13(11):1305-15. PubMed ID: 16712471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.